Across
- 2. city where the future recombinant portfolio of CSLB will be produced (hint: in Confoederatio Helvetica)
- 3. your favorite tool, with which you will never get lost
- 4. which product name contains the 17. letter from the Greek alphabet?
- 5. an antibody against a coagulation factor that interferes with coagulation factor function and complicates replacement therapy
- 7. what does the P in CIDP stand for
- 8. greipniv?
- 9. which coagulation disorder is known for its 3 subtypes
- 13. family name of the new EVP ComOps worldwide CSLB taking over as of today (july 1st)
- 15. never promote…… (hint: Medical question!)
- 16. one of the ICO operating principles?
Down
- 1. which recombinant product was launched in two ICO markets in 2014?
- 3. older name for hemophilia B, the inherited factor IX deficiency
- 4. the SPC for Hizentra states that one of its indications is: “Replacement therapy in myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and [?].
- 6. song title by Elvis that has something in common with a customary way of Ministries of Health to purchase medical products?
- 10. one of the CSLB values?
- 11. name of the award that CSL Behring received in 2012 by The European Organization for Rare Disorders for its pioneering work in developing and manufacturing therapies used to treat rare and serious medical conditions
- 12. medical event where pharmaceutical companies can collect input from HCPs about scientific questions
- 14. what is the main ingredient of Human Plasma?
- 17. name of the trial in which it is shown that Berinert was the least costly on-demand treatment option for HAE in a typical patient with 75 kg per body weight needing three vials per treatment episode